Evidence map›Paper›PMID 41458932›Full record

ArticleNeuro-oncology practice2025

Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residents.

Elizabeth C Neil, Aubree Bruhnding, Zubair A Ahmed, Priya U Kumthekar, Nicholas A Blondin, Christian Grommes, Chirag B Patel, Sigmund Hsu, Feng Wang, Hongyu Miao and 4 more

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elizabeth C NeilDepartment of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0009-0001-6830-5308
Aubree BruhndingBellin Health Neurology, Green Bay, Wisconsin, USA.ORCID https://orcid.org/0000-0002-1195-880X
Zubair A AhmedNeurosciences, Apex Medical, Chicago, Illinois, USA.
Priya U KumthekarDepartment of Neurology, Northwestern University, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-5923-0677
Nicholas A BlondinDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Christian GrommesDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Chirag B PatelDepartment of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Texas, USA.
Sigmund HsuDepartment of Neurosurgery, UTHealth Houston, Houston, Texas, USA.
Feng WangDepartment of Biostatistics & Data Science, UTHealth Houston, Houston, Texas, USA.
Hongyu MiaoCollege of Nursing, Florida State University, Tallahassee, Florida, USA.
Noah L RosenDepartment of Neurology, Zucker School of Medicine at Northwell Health, Manhasset, New York, USA.
Rashmi B Halker SinghDepartment of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Mark J BurishDepartment of Neurosurgery, UTHealth Houston, Houston, TX, USA.
Zachary A CorbinDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background: Neuro-oncology education in American neurology departments is highly variable, with no clear guidelines on appropriate practices. To better understand its current state, we focus on the perspective of departmental Grand Rounds (GR), views of adult neurology residency program directors (ANRPD), neuro-oncologists, and residents. Methods: First, we obtained GR series from academic years 2017-2018 and 2018-2019 via an online search and direct emails to neurology residency programs. Second, two online surveys were dispensed to ANRPD and neuro-oncologists. Third, a cohort of neurology residents completed surveys with pre/post-didactic tests. Results: Neuro-oncology consisted of 7% (28/ 411) GR in 2017-2018 and 6% (29/463) in 2018-2019; approximately 20% of institutions had no neuro-oncology GR. Twenty neuro-oncologists and 25 of the 175 ANRPDs completed the surveys. Respondents thought 1-to-4 GR annually was adequate. Thirty-five residents completed the survey. Residents might consider neuro-oncology with more exposure (77%, 27/35) and a stronger knowledge base (57%, 20/35). After 8-hours of didactics, residents demonstrated significant ( Conclusions: Here, we begin to define the status of several aspects of neuro-oncology education: 1 in 5 academic institutions do not have any neuro-oncology GR lectures annually, and both ANRPDs and neuro-oncologists agree that 1-to-4 lectures annually are adequate. Residents overwhelmingly stated they would be more interested in neuro-oncology with more exposure, and a pilot study of 8 hours of didactic did show knowledge improvement. While these initial datasets require confirmation in larger studies, it suggests that small changes to the current state at some institutions could have a meaningful impact.

Indexed as

didacticsgrand roundsneuro-oncology

Identifiers

PMID41458932
PMCPMC12741823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.